Page last updated: 2024-11-13

mk0767

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

MK0767: dual PPARalpha/gamma agonist, displays robust antihyperglycemic and hypolipidemic activities [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID56842109
CHEMBL ID4297404
MeSH IDM0468074

Synonyms (14)

Synonym
(+-)-5-((2,4-dioxothiazolidin-5-yl)methyl)-2-methoxy-n-(((4-trifluoromethyl)phenyl)methyl)benzamide
unii-y180u02gsb
mk 0767
2-methoxy-5-(2,4-dioxo-5-thiazolidinyl)-n-((4-(trifluoromethyl)phenyl)methyl)benzamide
benzamide, 5-((2,4-dioxo-5-oxazolidinyl)methyl)-2-methoxy-n-((4-(trifluoromethyl)phenyl)methyl)-
mk0767
y180u02gsb ,
934017-32-0
DB12055
orzmuvmqjpgfom-uhfffaoysa-n
BCP30796
mk-0767; mk0767
CHEMBL4297404
AKOS040753079

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" In rats dosed orally with [14C]MK-0767, a dihydrohydroxy-S-glutathionyl conjugate of the parent compound was identified in the bile using liquid chromatography-mass spectometry and 1H NMR techniques."( Identification and metabolism of a novel dihydrohydroxy-S-glutathionyl conjugate of a peroxisome proliferator-activated receptor agonist, MK-0767 [(+/-)-5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy-N-[[(4-trifluoromethyl) phenyl]methyl]benzamide], in r
Creighton, M; Doss, GA; Franklin, RB; Karanam, BV; Kochansky, CJ; Reddy, VB; Vincent, SH, 2004
)
0.32
" Concentrations of I and its major metabolites in rat urine were determined in samples collected between 0-24 h after dosing on the last day of administration of nine daily oral doses to three male (1000 mg/kg/day) and three female (300 mg/kg/day) Sprague-Dawley rats."( Simultaneous determination of MK-0767 and seven metabolites in rat urine using liquid chromatography/tandem mass spectrometry.
Bakhtiar, R; Franklin, RB; Kochansky, C; Shen, Z; Vincent, SH, 2004
)
0.32
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's12 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (25.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (75.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]